derived from @amb005 (thanks for the share) article above...$33m market cap and a leader in europe. sounds like that's where the focus should be rather than the US where every man and his is involved. "...Benhaim can take solace in knowing Elixinol is still a leader in the UK and Europe, a growth market where it has a strong position in hemp-derived CBD nutraceuticals. But structural challenges remain in the US Elixinol LLC itself hails from Colorado where a slower than expected regulatory progress prevails, leading to an "under-regulated, oversupplied and highly competitive market".
EXL Price at posting:
15.8¢ Sentiment: None Disclosure: Not Held
is involved.
